Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coronary Sinus Reducer Objective Impact on SymptoMs, Ischaemia and miCrovascular Resistance in Non-obstructive Hypertrophic CardioMyopathy

NCT07865364 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT07865364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07865364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coronary Sinus Reducer Objective Impact on SymptoMs, Ischaemia and miCrovascular Resistance in Non-obstructive Hypertrophic CardioMyopathy
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
September 30, 2029
Enrollment
50 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic cardiomyopathy